These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8319371)

  • 1. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
    Malhotra A; Poon E; Tse WY; Pringle PJ; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):393-8. PubMed ID: 8319371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WR; Shalet SM
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1869-75. PubMed ID: 7775634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WH; Holly JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
    Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
    Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.
    Stanhope R; Buchanan CR; Fenn GC; Preece MA
    Arch Dis Child; 1988 May; 63(5):501-5. PubMed ID: 3389864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.
    Link K; Blizzard RM; Evans WS; Kaiser DL; Parker MW; Rogol AD
    J Clin Endocrinol Metab; 1986 Jan; 62(1):159-64. PubMed ID: 3940264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
    Clayton PE; Shalet SM; Price DA; Addison GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):123-30. PubMed ID: 3248354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
    Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
    J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
    J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of changing gonadotropin-releasing hormone pulse frequency on puberty.
    Bridges NA; Hindmarsh PC; Matthews DR; Brook CG
    J Clin Endocrinol Metab; 1994 Sep; 79(3):841-7. PubMed ID: 8077371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
    Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.
    Soliman AT; Nasr I; Thabet A; Rizk MM; El Matary W
    Metabolism; 2005 Jan; 54(1):15-23. PubMed ID: 15562375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations.
    Dupuis CC; Storr HL; Perry LA; Ho JT; Ahmed L; Ong KK; Dunger DB; Monson JP; Grossman AB; Besser GM; Savage MO
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):838-43. PubMed ID: 17437509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
    Albanese A; Kewley GD; Long A; Pearl KN; Robins DG; Stanhope R
    Arch Dis Child; 1994 Oct; 71(4):315-7. PubMed ID: 7979523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
    Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.